Ledger.Open graph →
SEC Form D · filed June 15, 2023

Elucida Oncology, Inc

Offering
$40.0M
Sold
$22.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Ulrich Wiesner · Monmouth Junction, NJDirectorNatalie Macdonald · Monmouth Junction, NJDirectorGary Sender · Monmouth Junction, NJDirectorRobert Ruffolo · Monmouth Junction, NJDirectorGeno Germano · Monmouth Junction, NJExec · DirectorRobert Essner · Monmouth Junction, NJDirectorDavid Zacardelli · Monmouth Junction, NJDirectorTim Boris · Monmouth Junction, NJDirectorMichael Wolfgramm · Orem, UTExec · DirectorSpencer Patterson · Orem, UTDirectorGarheng S. Kong · Alpharetta, GADirectorRalph Yarro · Orem, UTDirectorJohn M. Courtright · Elmhurst, ILDirectorDaniel R. Myers · Alpharetta, GADirectorJonathan R. Simon · New York, NYDirectorPhilip S. Ashman · Alpharetta, GADirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorDion F. Chu · New York, NYDirectorMichael F. Peng · New York, NYDirectorHelene Servillon · Dover, DEExec · DirectorKara Forney · Albuquerque, NMDirectorDayah Energy GP, LLC · EATONTOWN, NJDirectorDayah Capital LLC · EATONTOWN, NJDirectorTerry J. Thib · Naples, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗